Skip To Main Content
Emma Wilkinson on Muck Rack

Emma Wilkinson

Sheffield
As seen in: The BMJ, Cell Press, Pulse Magazine, The Pharmaceutical Journal, The Limbic
Covers:  Health, medicine, science, NHS, public health, pharmacy
Award-winning freelance health journalist @pulsetoday, @bmj_latest, @PJOnline_News. Co-founder @freelancingfor. Vice-chair @mjauk. Runs up hills for fun.

Get in touch with Emma

Contact Emma, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Emma Wilkinson’s Biography

Read Full Bio →

I have worked as a freelance journalist for more than a decade specialising in biosciences, medicine, and health policy.

Before choosing the freelance route, I was a manuscript editor at The Lancet Oncology, clinical reporter at Pulse, and health reporter at BBC News online.

I write news and features for a wide range of outlets - print and digital - including medical journals and B2B publications.

I co-host the Freelancing for Journalists podcast and am co-author of the Freelancing for Journali…

Emma Wilkinson’s Journalist Portfolio

See all →
NHS hospitals not equipped to follow own advice on smoking cessation: audit

NHS hospitals not equipped to follow own advice on smoking cessation: audit

The NHS is missing many opportunities to help people quit smoking, the British Thoracic Society has warned af…

View article →
Rheumatology clinics struggling to review patients annually: audit

Rheumatology clinics struggling to review patients annually: audit

Only 43% of new inflammatory arthritis patients have had an annual review, new audit data suggests. Less than…

View article →
Post-Covid clinics underway for those with ongoing symptoms after discharge

Post-Covid clinics underway for those with ongoing symptoms after discharge

Clinicians around the country are doing their first face-to-face follow-up clinics for patients who recoverin…

View article →
Rheumatology departments facing uphill battle as 'normality' returns

Rheumatology departments facing uphill battle as 'normality' returns

As staff redeployment ends and hospitals restart routine care, the limbic talks to rheumatologists about the …

View article →
Treat-to-target still in 'too hard basket' for PsA

Treat-to-target still in 'too hard basket' for PsA

Barriers to rheumatologists adopting a treat-to-target approach in psoriatric arthritis (PsA), include lack o…

View article →
How mental health services are adapting to provide care in the pandemic

How mental health services are adapting to provide care in the pandemic

Emma Wilkinson talks to healthcare workers who are trying to ensure that vulnerable psychiatric patients do n…

View article →

Articles

Doctors are fighting to protect children from mouldy homes after death of Awaab Ishak

|
By Emma Wilkinson
| The BMJ Verified
In the wake of 2 year old’s death from mould exposure, doctors are battling to get children into safer homes that won’t wreck their health. Emma Wilkinson reports When Sonia Destouche moved into a local authority flat in Walthamstow, east London, in 2014, pregnant with her son, the ground floor flat was infested with ants and showing signs of damp and mould. Black patches spread across the bedroom floor and walls, turning green and grey with damp.
Open in Who Shared Issue with article?

Can the NHS afford Mounjaro? It spent £574m on the jab last year despite most eligible patients not getting it

|
By Emma Wilkinson
| The BMJ Verified
The NHS spent £574m on tirzepatide (Mounjaro) last year, an almost fivefold annual increase and around 5% of its total prescribing bill of £11.6bn, new data show. The increase—driven by rising prescription numbers and higher drug prices—comes despite most people who are eligible for the treatment on the NHS not yet being able to get it.
Open in Who Shared Issue with article?

One person a week in England dies with TB that was never diagnosed, study finds

|
By Emma Wilkinson
| The BMJ Verified
Almost one person a week dies with or from tuberculosis (TB) without ever having received a diagnosis, an analysis of UK data has shown. This should be a “never event,” and more work is needed to ensure timely detection of the condition, particularly among some high risk groups, the researchers concluded.
Open in Who Shared Issue with article?
See all 194 licensed articles (202 Total)